X
xinws.com
Digital healthcare platform for patient management solutions
About xinws.com
Shanghai Xinyun Pharmaceutical Technology Co., Ltd. operates a digital platform focused on healthcare services. The company aims to improve medical quality and the patient experience by enabling digital patient contact and management. Through its platform, patients can digitally initiate contact with healthcare centers, detail their symptoms, and receive automated follow-up questions. This information is then compiled into a medical report for the healthcare provider. This process is designed to streamline patient management and support both synchronous and asynchronous communication, such as video calls and chats.
The firm's offerings are part of a broader trend of integrating digital solutions into traditional primary care to manage large volumes of data, ensure regulatory compliance, and enhance the quality of care. In April 2019, the company, also known as Xinyun Medical, secured $2.98 million in a Series A funding round from investors including Jinke Junchuang Capital and Legend Star.
Source: Dealroom company dataAt a glance
- Founded
- 2011
- Headquarters
- Qingpu District, China
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- DVDalton Venture
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about xinws.com on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See xinws.com on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.